Product Information

BUPROPION HCL XL 300 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1002 per EA under NDC 16729044416. Its NADAC has been published 397 times since Apr 17, 2019.

FDA first approved this application on Oct 31, 2018. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL XL 300 MG TABLET

BUPROPION HYDROCHLORIDE
$0.1002per EA

Strength

300 mg/1

NDC

16729044416

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA210497

FDA Approved

10/31/2018

TE Code

AB3

On Market Since

3/25/2019

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 300 MG TABLET has been published 397 times since Apr 17, 2019, and over the history we have for it it has declined 73.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1002 per EA
All-time high$0.4702 (Sep 11, 2019)
All-time low$0.0982 (Oct 21, 2026)
52-week high$0.1385
52-week low$0.0982
Median price$0.1729
Average price$0.1910
Largest weekly change-33.9% (Sep 18, 2019)
Weeks tracked397
Tracking sinceApr 17, 2019

Price History

1W

+2.0%

1M

-0.3%

3M

-1.2%

6M

-13.2%

1Y

-27.7%

3Y

-46.7%

5Y

-44.7%

All

-73.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 300 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1002 per EA (NDC 16729044416), effective Nov 18, 2026.

How has the price of BUPROPION HCL XL 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 300 MG TABLET has declined 73.8%. It has been tracked across 397 weekly CMS publications since Apr 17, 2019.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 300 MG TABLET?

Since Apr 17, 2019, the NADAC for BUPROPION HCL XL 300 MG TABLET has ranged from a low of $0.0982 (Oct 21, 2026) to a high of $0.4702 (Sep 11, 2019), with a median of $0.1729 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 300 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 300 MG TABLET, is $0.0982 per EA — about 2% below BUPROPION HCL XL 300 MG TABLET.

Who manufactures BUPROPION HCL XL 300 MG TABLET?

BUPROPION HCL XL 300 MG TABLET (NDC 16729044416) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.